Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$16.48 USD
-0.32 (-1.90%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $16.47 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Arcus Biosciences, Inc. (RCUS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$39.22 | $70.00 | $23.00 | 133.45% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Arcus Biosciences, Inc. comes to $39.22. The forecasts range from a low of $23.00 to a high of $70.00. The average price target represents an increase of 133.45% from the last closing price of $16.80.
Analyst Price Targets (9 )
Broker Rating
Arcus Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 1.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.18 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, 10 are Strong Buy, representing 90.91% of all recommendations. A month ago, Strong Buy represented 90.91%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 9 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.18 | 1.18 | 1.18 | 1.20 | 1.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
8/9/2024 | Evercore Partners | Umer Raffat | Not Available | Strong Buy |
8/9/2024 | Cantor Fitzgerald & Co | Li Watsek | Strong Buy | Strong Buy |
7/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/4/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/16/2024 | SVB Securities | Daina M Graybosch | Strong Buy | Strong Buy |
2/13/2024 | Mizuho SecuritiesUSA | Salim Syed | Not Available | Strong Buy |
1/7/2024 | BTIG | Kaveri Pohlman | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.18 |
ABR (Last week) | 1.18 |
# of Recs in ABR | 11 |
Average Target Price | $39.22 |
LT Growth Rate | 7.80% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.86 |
RCUS FAQs
Arcus Biosciences, Inc. (RCUS) currently has an average brokerage recommendation (ABR) of 1.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms.
The average price target for Arcus Biosciences, Inc. (RCUS) is $39.22. The current on short-term price targets is based on 6 reports.
The forecasts for Arcus Biosciences, Inc. (RCUS) range from a low of $23 to a high of $70. The average price target represents a increase of $137.99 from the last closing price of $16.48.
The current UPSIDE for Arcus Biosciences, Inc. (RCUS) is 137.99%
Based on short-term price targets offered by nine analysts, the average price target for Arcus Biosciences, Inc. comes to $39.22. The forecasts range from a low of $23.00 to a high of $70.00. The average price target represents an increase of 133.45% from the last closing price of $16.80.